Prof Jan Tennent elected to AusBiotech Board

BioMedVic CEO Jan Tennent will have further opportunity to link Victoria’s health and medical research and clinical care with industry after being elected today to the AusBiotech Board of Directors.

The election outcome was announced at the 2017 Annual General Meeting of AusBiotech Ltd, held at the AusBiotech national conference at the Adelaide Convention Centre on 25 October 2017.

BioMedVic CEO Jan Tennent will have further opportunity to link Victoria’s health and medical research and clinical care with industry after being elected today to the AusBiotech Board of Directors.

The election outcome was announced at the 2017 Annual General Meeting of AusBiotech Ltd, held at the AusBiotech national conference at the Adelaide Convention Centre on 25 October 2017.

Jan Tennent is a respected senior executive and networked business leader with international and national experience in the pharmaceutical, biologicals, agribiotech and research sectors. She has a proven record of contribution and accomplishment in the governance and management of NFP organisations and highly matrixed organisations including CSIRO, CSL and Pfizer. Renowned for her trustworthiness and diligence, Jan brings innovation, expertise and focus to her roles.

In her previous role as Director for Business Development & Global Alliances at Pfizer Animal Health, Jan was responsible for maximising the growth and profitability of APAC business units and leading the due diligence and negotiation teams for a number of company and product acquisitions and numerous technology licenses and collaborative R&D agreements.

As a member of the CSL Animal Health executive team Jan was responsible for new product opportunity evaluation and leadership of product development and the launch teams for unique vaccines in Australia and the UK.

Jan brings expertise in forging and nurturing relationships and a persuasive advocacy style to her current role as CEO of Biomedical Research Victoria, the premier voice for linking health and medical research to clinical care in Victoria.

Jan’s research career included periods as Director of the CRC for Vaccine Technology and Program Manager for the Vaccines and Immunology group of CSIRO Animal Health. In these roles, Jan honed her innovation and management skills having oversight of the research and vaccine clinical trial activities of a 20-strong team.

An alumnus of Monash and Deakin universities, Jan was appointed in 2017 as Collaborative Professor at the University of Osaka.  She is a Principal Fellow at The University of Melbourne, Fellow of the Australian Society for Microbiology and Graduate of the Australian Institute of Company Directors.

Jan said: “I’m looking forward to leveraging my experience in the pharma, bio, agricultural and animal industries as well as research to contribute and add value to the terrific work that AusBiotech is already doing on behalf of its members.”